Cyclosporine and COVID-19: Risk or favorable?
Nadia Nicholine Poulsen, Albrecht von Brunn, Mads Hornum, Martin Blomberg Jensen
Topics & Concepts
MedicineARDSCytokine stormCoronavirusPandemicPopulationDiseaseCoronavirus disease 2019 (COVID-19)Intensive care medicineClinical trialImmunologyInternal medicineInfectious disease (medical specialty)LungEnvironmental healthCOVID-19 Clinical Research StudiesCOVID-19 Impact on ReproductionSARS-CoV-2 and COVID-19 Research